Capital Flow Monitor · Sponsors · CIK 1324240
OrbiMed Partners II, L.P.
601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY, 10022 · 212-739-6400
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$1.78B
% sold
—
Investors
880
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | D/A ·current | 506(b) | — | $1.78B | — | 880 | EDGAR ↗ |
| 2025-07-10 | D/A | 506(b) | — | $1.78B | — | 880 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- - OrbiMed Advisors LLC — Executive Officer / Promoter, NEW YORK, NY
- Sven H. Borho — Executive Officer, NEW YORK, NY
- Carl L. Gordon — Executive Officer, NEW YORK, NY
- W. Carter Neild — Executive Officer, NEW YORK, NY
- Geoffrey C. Hsu — Executive Officer, NEW YORK, NY
- C. Scotland Stevens — Executive Officer, New York, NY
- David Bonita — Executive Officer, New York, NY
- Matthew S. Rizzo — Executive Officer, New York, NY
- Peter A. Thompson — Executive Officer, New York, NY
- Mona Ashiya — Executive Officer, New York, NY
Placement agents
- Far Hills Group, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.